Ann Hematol
Annals of Hematology
0939-5555
1432-0584
Springer-Verlag
Berlin/Heidelberg


2226003
18066546
416
10.1007/s00277-007-0416-1
Review Article


Iron and thrombosis

Franchini
Massimo

+39-045-8124321
+39-045-8124626
mfranchini@univr.it

1
4

Targher
Giovanni

2

Montagnana
Martina

3

Lippi
Giuseppe

3

1
Servizio di Immunoematologia e Trasfusione, Centro Emofilia, Azienda Ospedaliera di Verona, Verona, Italy 
2
Sezione di Endocrinologia e Malattie del Metabolismo, Dipartimento di Scienze Biomediche e Chirurgiche, Università di Verona, Verona, Italy 
3
Istituto di Chimica e Microscopia Clinica, Dipartimento di Scienze Biomediche e Morfologiche, Università di Verona, Verona, Italy 
4
Servizio di Immunoematologia e Trasfusione, Centro Emofilia, Ospedale Policlinico, Piazzale Ludovico Scuro, 37134 Verona, Italy 

8
12
2007

3
2008

87
3
167
173
30
8
2007

11
11
2007


© Springer-Verlag 2007

Although essential for cell physiology, an increase or depletion of body iron has harmful effects on health. Apart from iron deficiency anemia and iron overload-related organ tissue damage, there are increasing evidences that body iron status is implicated in atherosclerotic cardiovascular diseases. The hypothesis formulated in 1981 that iron depletion may protect against cardiovascular events is intriguing and has generated a significant debate in the last two decades. Indeed, to study this phenomenon, several investigators have tried to design appropriate experimental and clinical studies and to identify useful biochemical and genetic markers of iron status. The results of the literature on the effect of iron deficiency and overload on vascular health are critically reviewed in this study from a pathogenic and clinical point of view.

Keywords
Iron
Thrombosis
Anemia

issue-copyright-statement
© Springer-Verlag 2008




Introduction
Iron is an essential nutrient for living cells because of its role as a cofactor for enzymes in the mitochondrial respiration chain, in the DNA synthesis, and being the central molecule for binding and transport of oxygen by hemoglobin and myoglobin.
1
7
].
This review will analyze, from a clinical and pathogenic point of view, the existing literature data on the relationship between iron and arterial and venous thrombosis.

Iron deficiency and thrombosis
8
26
27
28
].
29
9
26
13
30
] found that severe anemia, along with thrombophilia and hypercholesterolemia, were independent risk factors for cerebral venous thrombosis.
31
32
27
33
34
35
36
37
23
].
13
26
13
38
1
13
39
40
].

Iron overload and thrombosis
7
41
44
41
dl
42
44
].
45
47
48
53
54
55
56
57
] observed either no association (in Caucasian men) or a possible nonsignificant increased risk (in Caucasian women) of cardiovascular or coronary heart disease death among individuals with low ferritin concentrations.
7
58
72
61
65
64
71
60
61
69
70
72
61
] found that the mean serum ferritin concentrations were slightly higher in coronary heart disease patients than in controls, but this difference disappeared after adjusting for sex and C-reactive protein.
HFE
HFE
73
88
75
77
].
75
76
77
78
] found an association between increased iron stores and impaired endothelial function (measured as endothelium-dependent dilation and intima-media thickness) in patients homozygous for C282Y mutation. Iron-depletion therapy normalized the endothelial function in such patients thus reducing the increased risk of cardiovascular events.
61
79
89
61
80
81
HFE
86
HFE
89
79
].
90
94
].
95
].
1
Table 1
Summary of the most important studies on the association between HFE gene mutations (C282Y and H63D) and the risk of cardiovascular diseases

Authors [reference]
Study design
Population
Results


75
]
Prospective
1,150 individuals
C282Y heterozygosity is associated with a 2.3 RR for AMI compared with noncarriers

76
]
Prospective
12,239 postmenopausal women
C282Y heterozygosity is associated with a 1.6 RR for TCD compared with noncarriers

77
]
Prospective
243 CHD cases and 535 controls
C282Y heterozygosity is associated with a 2.7 RR for CHT compared with noncarriers

78
]
Case–control
41 C282Y/C282Y cases and 51 controls
C282Y homozygosity is associated with impaired endothelial function

61
]
Case–control
546 CHD cases and 303 controls
C282Y mutation is not associated with CHD

80
]
Case–control
1,098 subjects
C282Y mutation is not a risk factor for asymptomatic carotid atherosclerosis

81
]
Case–control
256 CHD cases and 272 controls
C282Y and H63D mutations are not associated with CHD

79
]
Prospective
9,178 individuals
C282Y and H63D mutations are not associated with CHD

Case–control
2,441 CHD and 1,113 AMI cases vs 8,080 controls
C282Y and H63D mutations are not associated with CHD

86
]
Case–control
482 CHD cases and 1,104 controls
C282Y mutation is not associated with CHD

88
]
Case–control
924 AMI cases and 1,029 controls
C282Y mutation is not associated with CHD

89
]
Case–control
907 individuals
HFE genotype is not related to brachial endothelial function and carotid atherosclerosis



AMI
CHD
RR
TCD
: total cardiovascular death




Conclusions
It is interesting to note that although with different pathogenic mechanisms, both iron deficiency and overload have been associated with an increased thrombotic risk in experimental and clinical studies.
However, several aspects need to be still elucidated in this field. In particular, large prospective controlled trials are needed to elucidate the role of genetic markers of iron stores and the impact of long-term iron depletion on morbidity and mortality from cardiovascular events.


References
1.
Gillum
RF

Sempos
CT

Makuc
DM

Looker
AC

Chien
CY

Ingram
DD


Serum transferrin saturation, stroke incidence, and mortality in women and men. The NHANES I Epidemiologic Followup Study. National Health and Nutrition Examination Survey
Am J Epidemiol
1996
144
59
68

8659486


2.
Keung
YK

Owen
J


Iron deficiency and thrombosis: literature review
Clin Appl Thromb Hemost
2004
10
387
391
10.1177/107602960401000412

15497026


3.
Kirkham
FJ


Stroke and cerebrovascular disease in childhood
Curr Open Pediatr
2003
13
350
359
10.1016/S0957-5839(03)00077-0

Kirkham FJ (2003) Stroke and cerebrovascular disease in childhood. Curr Open Pediatr 13:350–359 

4.
Dame
C

Sutor
AH


Primary and secondary thrombocytosis in childhood
Br J Haematol
2003
129
165
177
10.1111/j.1365-2141.2004.05329.x

15813844


5.
Chan
AK

Deveber
G

Monagle
P

Brooker
LA

Massicotte
PM


Venous thrombosis in children
J Thromb Haemost
2003
1
1443
1455
10.1046/j.1538-7836.2003.00308.x

12871279


6.
Ma
J

Stampfer
MJ


Body iron stores and coronary heart disease
Clin Chem
2002
48
601
603

11901057


7.
Sempos
CT


Do body iron stores increase the risk of developing coronary heart disease?
Am J Clin Nutr
2002
76
501
503

12197991


8.
Schloesser
LL

Kipp
MA

Wenzel
FJ


Thrombocytosis in iron-deficiency anemia
J Lab Clin Med
1965
66
107
114

Schloesser LL, Kipp MA, Wenzel FJ (1965) Thrombocytosis in iron-deficiency anemia. J Lab Clin Med 66:107–114 

9.
Ready
WK

Lowry
NJ


Anemia causing cerebral infarction in a child
CMAJ
1989
140
303
304

2914241


10.
Belman
AL

Roque
CT

Ancona
R

Anand
AK

Davis
RP


Cerebral venous thrombosis in a child with iron deficiency anemia and thrombocytosis
Stroke
1990
21
488
493

2309275


11.
Bruggers
CS

Ware
R

Altman
AJ

Rourk
MH

Vedanarayanan
V

Chaffee
S


Reversible focal neurologic deficits in severe iron deficiency anemia
J Pediatr
1990
117
430
432
10.1016/S0022-3476(05)81087-X

2167965


12.
Matsuoka
Y

Hayasaka
S

Yamada
K


Incomplete occlusion of central retinal artery in a girl with iron deficiency anemia
Ophthalmologica
1996
210
358
360

8887395


13.
Hartfield
DS

Lowry
NJ

Keene
DL

Yager
JY


Iron deficiency: a cause of stroke in infants and children
Pediatr Neurol
1997
16
50
53
10.1016/S0887-8994(96)00290-1

9044402


14.
Swann
IL

Kendra
JR


Severe iron deficiency anaemia and stroke
Clin Lab Haematol
2000
 22
221
223
10.1046/j.1365-2257.2000.00097.x

11012634


15.
Meena
AK

Naidu
KS

Murthy
JM


Cortical sinovenous thrombosis in a child with nephrotic syndrome and iron deficiency anaemia
Neurol India
2000
48
292
294

11025641


16.
Kirkham
TH

Wrigley
PF

Holt
JM


Central retinal vein occlusion complicating iron deficiency anaemia
Br J Ophthalmol
1971
55
777
780
10.1136/bjo.55.11.777

5129971


17.
Knizley
H

Noyes
WD


Iron deficiency anemia, papilledema, thrombocytosis, and transient hemiparesis
Arch Intern Med
1972
129
483
486
10.1001/archinte.129.3.483

5017685


18.
Alexander
MB


Iron deficiency anemia, thrombocytosis, and cerebrovascular accident
South Med J
1983
76
662
663

6844974


19.
Heller
DS

Pervez
NK

Kleinerman
J


Fatal cerebrovascular thrombosis in a young woman: an unusual complication associated with hypochromic anemia and thrombocytosis following surgery
Mt Sinai J Med
1988
55
318
320

3266301


20.
Aoki
N

Sakai
T


Cerebral sinus thrombosis in patients with severe iron deficiency anaemia due to myoma uteri
Acta Neurochir (Wien)
1989
97
131
134
10.1007/BF01772824

2718805


21.
Stehle
G

Buss
J

Heene
DL


Noninfectious thrombosis of the superior sagittal sinus in a patient with iron deficiency anemia
Stroke
1991
22
414

2003314


22.
Saxena
VK

Brands
C

Crols
R

Moens
E

Marien
P

Deyn
PP


Multiple cerebral infarctions in a young patient with secondary thrombocythemia due to iron deficiency anemia
Acta Neurol (Napoli)
1993
15
297
302

8249673


23.
Akins
PT

Glenn
S

Nemeth
PM

Derdeyn
CP


Carotid artery thrombus associated with severe iron-deficiency anemia and thrombocytosis
Stroke
1996
27
1002
1005

8623090


24.
Kacer
B

Hattenbach
LO

Horle
S

Scharrer
I

Kroll
P

Koch
F


Central retinal vein occlusion and nonarteritic ischemic optic neuropathy in 2 patients with mild iron deficiency anemia
Ophthalmologica
2001
215
128
131
10.1159/000050843

11244344


25.
Benedict
SL

Bonkowsky
JL

Thompson
JA

Orman
CB

Boyer
RS

Bale
JF

Filloux
FM


Cerebral sinovenous thrombosis in children: another reason to treat iron deficiency anemia
J Child Neurol
2004
19
526
531
10.1177/08830738040190070901

15526958


26.
Kinoshita
Y

Taniura
S

Shishido
H

Nojima
T

Kamitani
H

Watanebe
T


Cerebral venous sinus thrombosis associated with iron deficiency: two case reports
Neurol Med Chir (Tokyo)
2006
46
589
593
10.2176/nmc.46.589

17185884


27.
Dan
K


Thrombocytosis in iron deficiency anemia
Intern Med
2005
44
1025
1026
10.2169/internalmedicine.44.1025

16293910


28.
Dickeroff
R

Ruecker
A


Thrombozytose im Kindesalter. Differentialdiagnose und klinische Bedeutung
Paediatrische Praxis
1991
41
25
28

Dickeroff R, von Ruecker A (1991) Thrombozytose im Kindesalter. Differentialdiagnose und klinische Bedeutung. Paediatrische Praxis 41:25–28 

29.
Nagai
T

Komatsu
N

Sakata
Y

Miura
Y

Ozawa
K


Iron deficiency anemia with marked thrombocytosis complicated by central retinal vein occlusion
Intern Med
2005
44
1090
1092
10.2169/internalmedicine.44.1090

16293924


30.
Stolz
E

Valdueza
JM

Grebe
M

Schlachetzki
F

Schmitt
E

Madlener
K

Rahimi
A

Kempkes-Matthes
B

Blaes
F

Gerriets
T

Kaps
M


Anemia as a risk factor for cerebral venous thrombosis? An old hypothesis revisited: results of a prospective study
J Neurol
2007
254
729
734
10.1007/s00415-006-0411-9

17450317


31.
Karpatkin
S

Garg
S

Freedman
M


Role of iron as a regulator of thrombopoiesis
Am J Med
1974
57
521
525
10.1016/0002-9343(74)90001-1

4611205


32.
Beguin
Y


Erythropoietin and platelet production
Haematologica
1999
84
541
547

10366799


33.
Akan
H

Guven
N

Aydogdu
I

Arat
M

Beksac
M

Dalva
K


Thrombopoietic cytokines in patients with iron deficiency anemia with or without thrombocytosis
Acta Haematol
2000
103
152
156
10.1159/000041038

10940653


34.
Bilic
E

Bilic
E


Amino acid sequence homology of thrombopoietin and erythropoietin may explain thrombocytosis in children with iron deficiency anemia
J Pediatr Hematol Oncol
2003
25
675
676
10.1097/00043426-200308000-00023

12902931


35.
Racke
F


EPO and TPO sequences do not explain thrombocytosis in iron deficiency anemia
J Pediatr Hematol Oncol
2003
25
919
10.1097/00043426-200311000-00019

14608206


36.
Geddis
AE

Kaushansky
K


Cross-reactivity between erythropoietin and thrombopoietin at the level of Mpl does not account for the thrombocytosis seen in iron deficiency
J Pediatr Hematol Oncol
2003
25
919
920
10.1097/00043426-200311000-00020

14608207


37.
Tekin
D

Yavuzer
S

Tekin
M

Akar
N

Cin
S


Possible effects of antioxidant status on increased platelet aggregation in childhood iron-deficiency anemia
Pediatr Int
2001
43
74
77
10.1046/j.1442-200x.2001.01329.x

11208005


38.
Balci
K

Utku
U

Asil
T

Buyukkoyuncu
N


Deep cerebral vein thrombosis associated with iron deficiency anaemia in adults
J Clin Neurosci
2007
14
181
184
10.1016/j.jocn.2005.09.020

17161294


39.
Young
RS

Rannels
DE

Hilmo
A

Gerson
JM

Goodrich
D


Severe anemia in childhood presenting as transient ischemic attacks
Stroke
1983
14
622
623

6658942


40.
Hart
RG

Kanter
MG


Hematologic disorders and ischemic stroke. A selective review
Stroke
1990
21
1111
1121

2202092


41.
Day
SM

Duquaine
D

Mundada
LV

Menon
RG

Khan
BV

Rajagopalan
S

Fay
WP


Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis
Circulation
2003
107
2601
2606

12732602


42.
Zweier
JL

Broderick
R

Kuppusamy
P

Thompson-Gorman
S

Lutty
GA


Determination of the mechanism of free radical generation in human aortic endothelial cells exposed to anoxia and reoxygenation
J Biol Chem
1994
26
24156
24162

7929072


43.
Araujo
JA

Romano
EL

Brito
BE

Parthe
V

Romano
M

Bracho
M

Montano
RF

Cardier
J


Iron overload augments the development of atherosclerotic lesions in rabbits
Arterioscler Thromb Vasc Biol
1995
15
1172
1180

7542998


44.
Lee
TS

Shiao
MS

Pan
CC

Chau
LY


Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice
Circulation
1999
99
1222
1229

10069791


45.
Sullivan
JL


Iron and the sex difference in heart disease risk
Lancet
1981
1
1293
1294
10.1016/S0140-6736(81)92463-6

6112609


46.
Sullivan
JL


The iron paradigm of ischemic heart disease
Am Heart J
1989
117
1177
1188
10.1016/0002-8703(89)90887-9

2653014


47.
Sullivan
JL


Are menstruating women protected from heart disease because of, or in spite of, estrogen? Relevance to the iron hypothesis
Am Heart J
2003
145
190
194
10.1067/mhj.2003.142

12595829


48.
Meyers
DG


The iron hypothesis: does iron play a role in atherosclerosis?
Transfusion
2000
40
1023
1029
10.1046/j.1537-2995.2000.40081023.x

10960533


49.
Meyers
DG

Strickland
D

Maloley
PA

Seburg
JK

Wilson
JE

McManus
BF


Possible association of a reduction in cardiovascular events with blood donation
Heart
1997
78
188
193

9326996


50.
Meyers
DG

Jensen
KC

Menitove
JE


A historical cohort study of the effect of lowering body iron through blood donation on incident cardiac events
Transfusion
2002
42
1135
1139
10.1046/j.1537-2995.2002.00186.x

12430669


51.
Tuomainen
TP

Salonen
R

Nyyssonen
K

Salonen
JT


Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland
BMJ
1997
314
793
794

9080998


52.
Ascherio
A

Rimm
EB

Giovannucci
E

Willett
WC

Stampfer
MJ


Blood donations and risk of coronary heart disease in men
Circulation
2001
103
52
57

11136685


53.
Salonen
JT

Tuomainen
TP

Salonen
R

Lakka
TA

Nyyssonen
K


Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study
Am J Epidemiol
1998
148
445
451

9737556


54.
Zheng
H

Cable
R

Spencer
B

Votto
N

Katz
SD


Iron stores and vascular function in voluntary blood donors
Arterioscler Thromb Vasc Biol
2005
25
1577
1583
10.1161/01.ATV.0000174126.28201.61

15961703


55.
Duffy
SJ

Biegelsen
ES

Holbrook
M

Russell
JD

Gokce
N

Keaney
JF

Vita
JA


Iron chelation improves endothelial function in patients with coronary artery disease
Circulation
2001
103
2799
2804

11401935


56.
Zacharski
LR

Chow
BK

Howes
PS

Shamayeva
G

Baron
JA

Dalman
RL

Malenka
DJ

Ozaki
CK

Lavori
PW


Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial
JAMA
2007
297
603
610
10.1001/jama.297.6.603

17299195


57.
Sempos
CT

Looker
AC

Gillum
RE

McGee
DL

Vuong
CV

Johnson
CL


Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study. National Health and Nutrition Examination Study
Ann Epidemiol
2000
10
441
448
10.1016/S1047-2797(00)00068-5

11023623


58.
van der
A DL

Peeters
PH

Grobbee
DE

Marx
JJ

Schouw
YT


Dietary haem iron and coronary heart disease in women
Eur Heart J
2005
26
257
262
10.1093/eurheartj/ehi027

15618055


59.
Ramakrishna
G

Rooke
TW

Cooper
LT


Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light
Vasc Med
2003
8
203
210
10.1191/1358863x03vm493ra

14989563


60.
Haidari
M

Javadi
E

Sanati
A

Hajilooi
M

Ghanbili
J


Association of increased ferritin with premature coronary stenosis in men
Clin Chem
2001
47
1666
1672

11514401


61.
Bozzini
C

Girelli
D

Tinazzi
E

Olivieri
O

Stranieri
C

Bassi
A

Trabetti
E

Faccini
G

Pignatti
PF

Corrocher
R


Biochemical and genetic markers of iron status and the risk of coronary artery disease: an angiography-based study
Clin Chem
2002
48
622
628

11901060


62.
Salonen
JT

Nyyssonen
K

Korpela
H

Tuomilehto
J

Seppanen
R

Salonen
R


High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men
Circulation
1992
86
803
811

1516192


63.
Salonen
JT

Nyyssonen
K

Salonen
R


Body iron stores and the risk of coronary heart disease
N Engl J Med
1994
331
1159
10.1056/NEJM199410273311714

7935647


64.
Kiechl
S

Willeit
J

Egger
G

Poewe
W

Oberhollenzer
F


Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study
Circulation
1997
96
3300
3307

9396420


65.
Morrison
HI

Semenciw
RM

Mao
Y

Wigle
DT


Serum iron and risk of fatal acute myocardial infarction
Epidemiology
1994
5
243
246
10.1097/00001648-199403000-00015

8173000


66.
Gillum
RF


Body iron stores and atherosclerosis
Circulation
1997
96
3261
3263

9396411


67.
Valk
B

Marx
JJ


Iron, atherosclerosis, and ischemic heart disease
Arch Intern Med
1999
159
1542
1548
10.1001/archinte.159.14.1542

10421276


68.
Niederau
C


Iron overload and atherosclerosis
Hepatology
2000
32
672
674
10.1053/jhep.2000.17921

10960469


69.
Danesh
J

Appleby
P


Coronary heart disease and iron status: meta-analyses of prospective studies
Circulation
1999
99
852
854

10027804


70.
Sempos
CT

Looker
AC

Gillum
RF

Makuc
DM


Body iron stores and the risk of coronary heart disease
N Engl J Med
1994
330
1119
1124
10.1056/NEJM199404213301604

7993405


71.
Wolff
B

Volzke
H

Ludemann
J

Robinson
D

Vogelgesang
D

Staudt
A

Kessler
C

Dahm
JB

John
U

Felix
SB


Association between high serum ferritin levels and carotid atherosclerosis in the study of health in Pomerania (SHIP)
Stroke
2004
35
453
457
10.1161/01.STR.0000114875.31599.1C

14726541


72.
Auer
J

Rammer
M

Berent
R

Weber
T

Lassnig
E

Eber
B


Body iron stores and coronary atherosclerosis assessed by coronary angiography
Nutr Metab Cardiovasc Dis
2002
12
285
290

12616808


73.
Hu
FB


The iron-heart hypothesis
JAMA
2007
297
639
641
10.1001/jama.297.6.639

17299200


74.
Sullivan
JL


Iron and the genetics of cardiovascular disease
Circulation
1999
100
1260
1263

10491367


75.
Tuomainen
TP

Kontula
K

Nyyssonen
K

Lakka
TA

Helio
T

Salonen
JT


Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: a prospective cohort study in men in eastern Finland
Circulation
1999
100
1274
1279

10491370


76.
Roest
M

Schouw
YT

Valk
B

Marx
JJ

Tempelman
MJ

Groot
PG

Sixma
JJ

Banga
JD


Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women
Circulation
1999
100
1268
1273

10491369


77.
Rasmussen
ML

Folsom
AR

Catellier
DJ

Tsai
MY

Garg
U

Eckfeldt
JH


A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk in Communities (ARIC) study
Atherosclerosis
2001
154
739
746
10.1016/S0021-9150(00)00623-7

11257277


78.
Gaenzer
H

Marschang
P

Sturm
W

Neumayr
G

Vogel
W

Patsch
J

Weiss
G


Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis
JACC
2002
40
2189
2194

12505233


79.
Ellervik
C

Tybjaerg-Hansen
A

Grande
P

Appleyard
M

Nordestgaard
BG


Hereditary hemochromatosis and risk of ischemic heart disease: a prospective study and a case–control study
Circulation
2005
112
185
193
10.1161/CIRCULATIONAHA.104.496075

15998685


80.
Rossi
E

McQuillan
BM

Hung
J

Thompson
PL

Kuek
C

Beilby
JP


Serum ferritin and C282Y mutation of the hemochromatosis gene as predictors of asymptomatic carotid atherosclerosis in a community population
Stroke
2000
31
3015
3020

11108765


81.
Franco
RF

Zago
MA

Trip
MD

ten Cate
H

Ende
A

Prins
MH

Kastelein
JJ

Reitsma
PH


Prevalence of hereditary haemochromatosis in premature atherosclerotic vascular disease
Br J Haematol
1998
102
1172
1175
10.1046/j.1365-2141.1998.00898.x

9753040


82.
Battiloro
E

Ombres
D

Pascale
E

D

'Ambrosio
E

Verna
R

Arca
M


Haemochromatosis gene mutations and risk of coronary artery disease
Eur J Hum Genet
2000
8
389
392
10.1038/sj.ejhg.5200465

10854101


83.
Hetet
G

Elbaz
A

Gariepy
J

Nicaud
V

Arveiler
D

Morrison
C

Kee
F

Evans
A

Simon
A

Amarenco
P

Cambien
F

Grandchamp
B


Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases
Eur J Clin Investig
2001
31
382
388
10.1046/j.1365-2362.2001.00829.x

11380589


84.
Claeys
D

Walting
M

Julmy
F

Wuillemin
WA

Meyer
BJ


Haemochromatosis mutations and ferritin in myocardial infarction: a case–control study
Eur J Clin Investig
2002
32
Suppl. 1
3
8
10.1046/j.1365-2362.2002.0320s1003.x

11886425


85.
Nassar
BA

Zayed
EM

Title
LM

O

'Neill
BJ

Bata
IR

Kirkland
SA

Dunn
J

Dempsey
GI

Tan
MH

Johnstone
DE


Relation of HFE gene mutations, high iron stores and early onset coronary artery disease
Can J Cardiol
1998
14
215
220

9520858


86.
Gunn
IR

Maxwell
FK

Gaffney
D

McMahon
AD

Packard
CJ


Haemochromatosis gene mutations and risk of coronary heart disease: a west of Scotland coronary prevention study (WOSCOPS) substudy
Heart
2004
90
304
306
10.1136/hrt.2003.015149

14966054


87.
Surber
R

Sigusch
HH

Kuehnert
H

Figulla
HR


Haemochromatosis (HFE) gene C282Y mutation and the risk of coronary artery disease and myocardial infarction: a study in 1279 patients undergoing coronary angiography
J Med Genet
2003
40
 e58
10.1136/jmg.40.5.e58

12746412


88.
Campbell
S

George
DK

Robb
SD

Spooner
R

McDonagh
TA

Dargie
HJ

Mills
PR


The prevalence of haemochromatosis gene mutations in the West of Scotland and their relation to ischaemic heart disease
Heart
2003
89
1023
1026
10.1136/heart.89.9.1023

12923017


89.
Yunker
LM

Parboosingh
JS

Conradson
HE

Faris
P

Bridge
PJ

Buithieu
J

Title
LM

Charbonneau
F

Verma
S

Lonn
EM

Anderson
TJ


The effect of iron status on vascular health
Vasc Med
2006
11
85
91
10.1191/1358863x06vm656oa

16886838


90.
Mahon
NG

Coonar
AS

Jeffery
S

Coccolo
F

Akiyu
J

Zal
B

Houlston
R

Levin
GE

Baboonian
C

McKenna
WJ


Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy
Heart
2000
84
541
547
10.1136/heart.84.5.541

11040018


91.
Hannuksela
J

Leppilampi
M

Peuhkurinen
K

Karkkainen
S

Saastamoinen
E

Helio
T

Kaartinen
M

Nieminen
MS

Nieminen
P

Parkkila
S


Hereditary hemochromatosis gene (HFE) mutations C282Y, H63D and S65C in patients with idiopathic dilated cardiomyopathy
Eur J Heart Fail
2005
7
103
108
10.1016/j.ejheart.2004.03.007

15642540


92.
Hetet
G

Grandchamp
B

Bouchier
C

Nicaud
V

Tiret
L

Roizes
G

Desnos
M

Schwartz
K

Dorent
R

Komajda
M

CARDIGENE Group

Idiopathic dilated cardiomyopathy: lack of association with haemochromatosis gene in the CARDIGENE study
Heart
2001
86
702
703
10.1136/heart.86.6.702

11711473


93.
Njajou
OT

Hollander
M

Koudstaal
PJ

Hofman
A

Witteman
JC

Breteler
MM

Duijn
CM


Mutations in the hemochromatosis gene (HFE) and stroke
Stroke
2002
23
2363
2366
10.1161/01.STR.0000029779.37078.C7

12364722


94.
Hruskovicova
H

Milanez
T

Kobal
J

Potisk
KP

Petrovic
D

Peterlin
B


Hemochromatosis-causing mutations C282Y and H63D are not risk factors for atherothrombotic cerebral infarction
Med Sci Monit
2005
11
 BR248
BR252

15990686


95.
MacLean
RM

Feeney
GP

Bowley
SJ

Bowen
DJ

Worwood
M

Collins
PW


Factor V Leiden and the common haemochromatosis mutation HFE C282Y: is there an association in familial venous thromboembolic disease?
Br J Haematol
1999
107
210
212
10.1046/j.1365-2141.1999.01663.x

10520044





